4-Propyl-1-naphthoic acid, 95.0%, 5g

tert-butyl N-[(3S,4R)-4-hydroxypiperidin-3-yl]carbamate, 97.0%, 250mg

Methyl 5-bromo-1H-pyrrole-2-carboxylate, 95.0%, 100mg

(3,5-DIFLUOROPYRIDIN-2-YL)METHANOL, 95.0%, 250mg

Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogenphosphate, 98.0%, 250mg

(R)-Fmoc-2-Amino-5-(trityl-carbamoyl)pentanoic acid, 97%, 250mg

5-Bromo-4-methyl-3-nitropyridin-2(1H)-one, 95.0%, 25g

(S)-3-METHYL-2-(1-OXOISOINDOLIN-2-YL)BUTANOIC ACID, 95.0%, 1g

GC capillary column ROTI®Cap-5, 10 m, 0.53 mm, 1.00 µm, 1 Piece(s)

6-Methoxy-2-methylbenzo[d]thiazole, 95.0%, 2.5g

2'-(Methylsulfonyl)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one, 97%, 100mg

Bismuth subsalicylate, USP, 100g, plastic wrap.

2-Chloro-5-(morpholine-4-sulfonyl)benzoic acid, 97%, 250mg